Alterity Therapeutics Limited (ATHE)

Alterity Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	18	11	25	44	17	12
Market Cap Growth	-59.51%	-54.13%	-44.28%	155.51%	46.89%	-30.25%
Enterprise Value	9	0	0	23	11	2
PE Ratio	-	-1.18	-2.75	-3.82	-1.86	-1.35
PB Ratio	1.49	0.72	1.00	1.92	3.49	1.01
P/FCF Ratio	-1.02	-0.81	-2.84	-3.38	-2.64	-1.19
P/OCF Ratio	-1.02	-0.81	-2.86	-3.38	-2.65	-1.19
EV/EBITDA Ratio	-	-	-0.05	-1.99	-1.18	-0.18
EV/EBIT Ratio	-0.21	-0.04	-0.05	-1.99	-1.18	-0.18
EV/FCF Ratio	-0.18	-0.03	-0.05	-1.76	-1.67	-0.16
Debt / Equity Ratio	-	-	0.00	0.00	0.00	-
Debt / EBITDA Ratio	-	-	-0.01	0.00	0.00	-
Debt / FCF Ratio	-	-	-0.01	0.00	0.00	-
Quick Ratio	4.07	5.58	6.79	10.56	3.41	5.79
Current Ratio	4.89	6.17	7.07	10.92	3.62	5.98
Return on Equity (ROE)	-53.70%	-47.40%	-39.00%	-81.40%	-113.50%	-75.60%
Return on Assets (ROA)	-44.20%	-40.20%	-34.30%	-70.40%	-90.30%	-63.90%
Return on Capital (ROIC)	-95.16%	-81.40%	-57.96%	-64.13%	-194.05%	-107.20%
Earnings Yield	-47.59%	-84.66%	-36.38%	-26.15%	-53.88%	-74.10%
FCF Yield	-55.52%	-122.90%	-35.19%	-29.62%	-37.83%	-83.85%
Buyback Yield / Dilution	-17.08%	-0.91%	-41.79%	-89.62%	-45.33%	-15.34%
Total Shareholder Return	-17.08%	-0.91%	-41.79%	-89.62%	-45.33%	-15.34%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).